Thompson Street Capital-backed Isto Biologics completed the merger with Biologica Technologies.

Thompson Street Capital-backed Isto Biologics, a biologics and cellular therapy company, completed the merger with Biologica Technologies, a medical devices, plastic, and reconstructive surgery services provider. Financial terms were not disclosed. "We are thrilled for our entire Advanced Biologics/Biologica team to join forces with Isto Biologics. This merger brings together the clinical, commercial, and research-driven expertise of both companies' and a shared commitment to help patients heal faster," Amit Govil, Biologica Technologies President.